ARVIND REMEDIES LIMITED
UNAUDITED FINANCIAL RESULTS
FOR THE QUARTER AND NINE MONHTS ENDED DECEMBER 31,  2005
		(Rupees in Lakhs.)
	Particulars	Three months ended 31.12.2005	Three months ended 31.12.2004	Corresponding nine months ended 31.12.2005	Corresponding nine months ended 31.12.2004	Year ended 31.3.2005
		Unaudited	Unaudited	Unaudited	Unaudited	Audited
	Gross Sales	3592.96	3,131.80	12,286.75	10,249.42	13,825.78
	Less: Excise Duty	(420.07)	(336.29)	(1,553.78)	(1,074.46)	(1,600.39)
	Net Sales	3,172.89	2,795.51	10,732.97	9,174.96	12,225.39
	Other Income	17.97	12.97	57.92	18.12	32.28
	Total Income	3,190.86	2,808.48	10,790.89	9,193.08	12,257.67
	Total expenditure :
	a)  (Increase) / Decrease in Stock	155.58	134.70	66.09	60.27	(611.06)
	b)  Materials Consumed	2473.91	2,158.62	8,985.37	7,528.65	10,851.22
	c)  Staff Cost	79.35	70.48	230.78	227.06	267.92
	d)  Other expenditure	245.98	224.30	560.25	538.33	822.76
	Total (a) to (d)	2,954.82	2,588.10	9,842.49	8,354.31	11,330.84
	Gross Profit before Interest & Depreciation	236.04	220.38	948.40	838.77	926.83
	Interest	86.78	107.56	333.57	303.13	418.08
	Depreciation	37.36	36.43	113.64	103.03	142.33
	Profit before Tax	111.90	76.39	501.19	432.61	366.42
	Provision for Taxation
	Income Tax (Including Fringe Benefit Tax)	20.00	20.00	80.00	80.00	45.00
	Earlier years	8.97	-	9.87	-	0.90
	Deferred Tax	(16.81)	(6.86)	(27.35)	(37.10)	133.52
	Wealth Tax		-		-	0.33
	Profit / (Loss) after Tax	99.74	63.25	438.67	389.71	186.67
	Paid-up Equity Share Capital	2600.50	2600.50	2600.50	2600.50	2600.50
	(face value Re. 1/- per Share)
	Reserves excluding Revaluation Reserve	-	-	-	-	1,076.38
	Basic and Diluted Earnings Per Share (Rs.)	0.04	0.02	0.17	0.15	0.07
	Aggregate of Non-Promoter Shareholding
	Number of shares	194205340	191942905	194205340	191942905	197403955
	Percentage of Shareholding	74.68%	73.81%	74.68%	73.81%	75.91%
	Note :
	1. The Company operates only in one business segment namely  formulations.
	2. Previous period's figures have been regrouped / rearranged  wherever necessary to confirm to the current periods classification.
	3. Provision for taxation for the nine months ended December 31, 2005 has been made on an estimate basis.  The actual tax liability will be determined on the basis of
	the taxable income of the Company for the year from April 1, 2005 to March 31, 2006.
	4. The above results were reviewed by the audit committee and taken on record at the meeting of the Board of Directors held on February 27, 2006.
	5. During the quarter 13 investor complaints were received and disposed off.  There were no investor complaints pending for the redressal as at the
	the commencement and end of the quarter.
	6. The above results for the quarter and nine months ended December 31, 2005 have been subjected to a Limited Review by the statutory auditors as per the listing agreement
	with the stock exchanges.
	Chennai - 600 084				For ARVIND REMEDIES LTD.
	Date: February 27, 2006
					Dr. B Arvind Shah
					CEO and Managing Director
						INDEX